Propecia, known in its generic form as Finasteride, is a common treatment for mail pattern hair loss. In some instances, Propecia is also prescribed to curb issues linked to an enlarged prostate. Propecia was originally produced by Merck in 1992 , originally marketed under the name Proscar, for the purposes of treating benign prostate tumors and treating male pattern baldness. In March 2011, an eye-opening study published by The Journal of Sexual Medicine showed a link between Propecia ingestion and various forms of sexual dysfunction. According to the study, it’s estimated that 15 percent of all men who used Propecia suffered some type of sexual dysfunction, even when they stopped taking the medication. In addition, anywhere between 5 to 23 percent of users may become impotent as a result of using Propecia. There were also statistically significant linkages between Propecia use and the development of breast tissue in men, diminished libido, and erectile dysfunction. Physicians sometimes prescribe finasteride for the treatment of benign prostatic hyperplasia (BPH), informally known as an enlarged prostate. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start and end of urination, and decreased urinary flow. It provides less symptomatic relief than alpha-1 blockers such as tamsulosin and symptomatic relief is slower in onset (six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment). Symptomatic benefits are mainly seen in those with prostate volume . In long-term studies finasteride but not alpha-1 inhibitors reduce the risk of acute urinary retention (−57% at 4 years) and the need for surgery (−54% at 4 years). If the drug is discontinued, any therapeutic benefits are reversed within about 6–8 months. A followup study of the Medicare claims of participants in a 10-year Prostate Cancer Prevention Trial suggests a significant reduction in prostate cancer risk is maintained even after discontinuation of treatment.
Patients with large residual urinary volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy. These patients may not be candidates for finasteride therapy. If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware. If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices. Another way to prevent getting this page in the future is to use Privacy Pass. Check out the browser extension in the Firefox Add-ons Store.
Medscape - Indication-specific dosing for Propecia, Proscar finasteride, frequency-based adverse. Hepatic impairment Caution in liver dysfunction; monitor. PROPECIA® is indicated for the treatment of male pattern hair loss. with liver function abnormalities, as finasteride is metabolized extensively in the liver see.